Global Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
The Global Spirometer Market is accounted to reach USD 1,041.3 million by 2024 from USD 553.9 million in 2016; it is growing at a CAGR of 8.3%.
The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.
The key market players for Global Spirometer Market are listed below:
Based on technology, the Global spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Global spirometer market with 67.3% market share and is expected to reach USD 719.5 million by 2024, growing at a CAGR of 8.7% in the forecast period 2017 to 2024.
Based on disease, the Global spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Global spirometer market with 40.5% market share and is expected to reach USD 438.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.
Based on disposable components, the Global spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Global spirometer market with 74.0% market share and is expected to reach USD 781.6 million by 2024, growing with the highest CAGR of 8.6% in the forecast period 2017 to 2024.
Based on application, the Global spirometer market is segmented into diagnostics and therapeutic. In 2017, diagnostics is expected to dominate the Global spirometer market with 65.4% market share and is expected to reach USD 707.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.
Based on end-user, the Global spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Global spirometer market with 50.0% market share and is expected to reach USD 537.0 million by 2024, growing at a CAGR of 8.8% in the forecast period 2017 to 2024.
Based on distribution channel, the Global spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Global spirometer market with 64.4% market share and is expected to reach USD 684.0 million by 2024, growing at a CAGR of 8.6% in the forecast period 2017 to 2024.
Based on geography, the Global Spirometer market is segmented into 11 geographical regions, such as,
The report covers the present scenario and the growth prospects of the Global Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.
The key market players for Global Spirometer Market are listed below:
- BD,
- Midmark Corp.
- Welch allyn
- SDI Diagnostics,
- Geratherm Respiratory GMBH,
- Type
- Application
- End User
- Geography
Based on technology, the Global spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Global spirometer market with 67.3% market share and is expected to reach USD 719.5 million by 2024, growing at a CAGR of 8.7% in the forecast period 2017 to 2024.
Based on disease, the Global spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Global spirometer market with 40.5% market share and is expected to reach USD 438.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.
Based on disposable components, the Global spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Global spirometer market with 74.0% market share and is expected to reach USD 781.6 million by 2024, growing with the highest CAGR of 8.6% in the forecast period 2017 to 2024.
Based on application, the Global spirometer market is segmented into diagnostics and therapeutic. In 2017, diagnostics is expected to dominate the Global spirometer market with 65.4% market share and is expected to reach USD 707.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.
Based on end-user, the Global spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Global spirometer market with 50.0% market share and is expected to reach USD 537.0 million by 2024, growing at a CAGR of 8.8% in the forecast period 2017 to 2024.
Based on distribution channel, the Global spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Global spirometer market with 64.4% market share and is expected to reach USD 684.0 million by 2024, growing at a CAGR of 8.6% in the forecast period 2017 to 2024.
Based on geography, the Global Spirometer market is segmented into 11 geographical regions, such as,
- North America,
- South America,
- Europe,
- APAC,
- MEA
The report covers the present scenario and the growth prospects of the Global Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL SPIROMETER MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL SPIROMETER MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6 PORTER’S FIVE FORCES MATRIX
2.2.7 PEST ANALYSIS
2.2.8. EPIDEMIOLOGY FORECASTING MODELS
2.3. GLOBAL SPIROMETER MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL SPIROMETER MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TABLE-TOP SPIROMETER
6.3. HAND-HELD SPIROMETER
6.4. DESKTOP(PC) SPIROMETER
7 GLOBAL SPIROMETER MARKET, BY TECHNOLOGY
7.1. OVERVIEW
7.2. VOLUME MEASUREMENT SPIROMETER(WET AND DRY)
7.3. FLOW MEASUREMENT SPIROMETER (PNEUMOTACHOGRAPH SYSTEM AND MASS FLOW METER)
7.4. PEAK FLOW METER (PFM)
8 GLOBAL SPIROMETER MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. DIAGNOSTIC
8.3. THERAPEUTIC
9 GLOBAL SPIROMETER MARKET, BY END USER
9.1. OVERVIEW
9.2. HOSPITALS
9.3. CLINIC
9.4. HOMECARE
10 GLOBAL SPIROMETER MARKET, BY APPLICATION
10.1. OVERVIEW
10.2. OVER THE COUNTER
10.3. DIRECT TENDER
11 GLOBAL SPIROMETER MARKET, BY GEOGRAPHY
11.1. COUNTRYWISE GLOBAL SPIROMETER MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1.1. NORTH AMERICA
11.1.1.1. U.S.
11.1.1.2. CANADA
11.1.1.3. MEXICO
11.1.2. EUROPE
11.1.2.1. GERMANY
11.1.2.2. FRANCE
11.1.2.3. U.K.
11.1.2.4 ITALY
11.1.2.5 SPAIN
11.1.2.6 RUSSIA
11.1.2.7 TURKEY
11.1.2.8 BELGIUM
11.1.2.9NETHERLANDS
11.1.2.10 SWITZERLAND
11.1.2.11 REST OF EUROPE
11.1.3 ASIA-PACIFIC (APAC)
11.1.3.1 JAPAN
11.1.3.2 CHINA
11.1.3.3 SOUTH KOREA
11.1.3.4 INDIA
11.1.3.5 AUSTRALIA
11.1.3.6 SINGAPORE
11.1.3.7 THAILAND
11.1.3.8 MALAYSIA
11.1.3.9 INDONESIA
11.1.3.10 PHILIPPINES
11.1.3.11 REST OF APAC
11.1.4 LATIN AMERICA
11.1.4.1 BRAZIL
11.1.4.2 REST OF LATIN AMERICA
11.1.5 MIDDLE EAST AND AFRICA
11.1.5.1 SOUTH AFRICA
11.1.5.2 REST OF MIDDLE EAST AND AFRICA
11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 GLOBAL SPIROMETER MARKET: COMPETITIVE LANDSCAPE
12.1. GLOBAL SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.2. NORTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.3. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.4. APAC SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.5. MEA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.6. SOUTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.7. MERGERS & ACQUISITIONS
12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
12.9. EXPANSIONS
12.10. REGULATORY CHANGES
12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES
13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES
13.1 WELCH ALLYN
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL ANALYSIS
13.1.3 PRODUCT MATRIX
13.1.4 RECENT DEVELOPMENTS
13.1.5 DATABRIDGE ANALYSIS
13.2 MIDMARK CORP.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL ANALYSIS
13.2.3 PRODUCT MATRIX
13.2.4 RECENT DEVELOPMENTS
13.2.5 DATABRIDGE ANALYSIS
13.3 FUTUREMED
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL ANALYSIS
13.3.3 PRODUCT MATRIX
13.3.4 RECENT DEVELOPMENTS
13.3.5 DATABRIDGE ANALYSIS
13.4 COSMED
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL ANALYSIS
13.4.4 PRODUCT MATRIX
13.4.4 RECENT DEVELOPMENTS
13.4.5 DATABRIDGE ANALYSIS
13.5 MGC DIAGNOSTICS CORPORATION
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL ANALYSIS
13.5.3 PRODUCT MATRIX
13.5.4 RECENT DEVELOPMENTS
13.5.5 DATABRIDGE ANALYSIS
13.6 NIHON KOHDEN CORPORATION
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL ANALYSIS
13.6.3 PRODUCT MATRIX
13.6.4 RECENT DEVELOPMENTS
13.6.5 DATABRIDGE ANALYSIS
13.7 CAREFUSION CORPORATION
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL ANALYSIS
13.7.3 PRODUCT MATRIX
13.7.4 RECENT DEVELOPMENTS
13.7.5 DATABRIDGE ANALYSIS
13.8 MEDICAL INTERNATIONAL RESEARCH
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL ANALYSIS
13.8.3 PRODUCT MATRIX
13.8.4 RECENT DEVELOPMENTS
13.8.5 DATABRIDGE ANALYSIS
13.9 VITALOGRAPH
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL ANALYSIS
13.9.3 PRODUCT MATRIX
13.9.4 RECENT DEVELOPMENTS
13.9.5 DATABRIDGE ANALYSIS
13.10 NDD MEDICAL TECHNOLOGIES, INC.
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL ANALYSIS
13.10.3 PRODUCT MATRIX
13.10.4 RECENT DEVELOPMENTS
13.10.5 DATABRIDGE ANALYSIS
13.11 SCHILLER AG
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL ANALYSIS
13.11.3 PRODUCT MATRIX
13.11.4 RECENT DEVELOPMENTS
13.11.5 DATABRIDGE ANALYSIS
13.12 JONES MEDICAL INSTRUMENT COMPANY
13.12.1 COMPANY OVERVIEW
13.12.2 FINANCIAL ANALYSIS
13.12.3 PRODUCT MATRIX
13.12.4 RECENT DEVELOPMENTS
13.12.5 DATABRIDGE ANALYSIS
14 APPENDIX
15 ABOUT DATA BRIDGE MARKET RESEARCH
1.1. OVERVIEW OF THE GLOBAL SPIROMETER MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL SPIROMETER MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6 PORTER’S FIVE FORCES MATRIX
2.2.7 PEST ANALYSIS
2.2.8. EPIDEMIOLOGY FORECASTING MODELS
2.3. GLOBAL SPIROMETER MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL SPIROMETER MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TABLE-TOP SPIROMETER
6.3. HAND-HELD SPIROMETER
6.4. DESKTOP(PC) SPIROMETER
7 GLOBAL SPIROMETER MARKET, BY TECHNOLOGY
7.1. OVERVIEW
7.2. VOLUME MEASUREMENT SPIROMETER(WET AND DRY)
7.3. FLOW MEASUREMENT SPIROMETER (PNEUMOTACHOGRAPH SYSTEM AND MASS FLOW METER)
7.4. PEAK FLOW METER (PFM)
8 GLOBAL SPIROMETER MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. DIAGNOSTIC
8.3. THERAPEUTIC
9 GLOBAL SPIROMETER MARKET, BY END USER
9.1. OVERVIEW
9.2. HOSPITALS
9.3. CLINIC
9.4. HOMECARE
10 GLOBAL SPIROMETER MARKET, BY APPLICATION
10.1. OVERVIEW
10.2. OVER THE COUNTER
10.3. DIRECT TENDER
11 GLOBAL SPIROMETER MARKET, BY GEOGRAPHY
11.1. COUNTRYWISE GLOBAL SPIROMETER MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
11.1.1. NORTH AMERICA
11.1.1.1. U.S.
11.1.1.2. CANADA
11.1.1.3. MEXICO
11.1.2. EUROPE
11.1.2.1. GERMANY
11.1.2.2. FRANCE
11.1.2.3. U.K.
11.1.2.4 ITALY
11.1.2.5 SPAIN
11.1.2.6 RUSSIA
11.1.2.7 TURKEY
11.1.2.8 BELGIUM
11.1.2.9NETHERLANDS
11.1.2.10 SWITZERLAND
11.1.2.11 REST OF EUROPE
11.1.3 ASIA-PACIFIC (APAC)
11.1.3.1 JAPAN
11.1.3.2 CHINA
11.1.3.3 SOUTH KOREA
11.1.3.4 INDIA
11.1.3.5 AUSTRALIA
11.1.3.6 SINGAPORE
11.1.3.7 THAILAND
11.1.3.8 MALAYSIA
11.1.3.9 INDONESIA
11.1.3.10 PHILIPPINES
11.1.3.11 REST OF APAC
11.1.4 LATIN AMERICA
11.1.4.1 BRAZIL
11.1.4.2 REST OF LATIN AMERICA
11.1.5 MIDDLE EAST AND AFRICA
11.1.5.1 SOUTH AFRICA
11.1.5.2 REST OF MIDDLE EAST AND AFRICA
11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
12 GLOBAL SPIROMETER MARKET: COMPETITIVE LANDSCAPE
12.1. GLOBAL SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.2. NORTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.3. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.4. APAC SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.5. MEA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.6. SOUTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
12.7. MERGERS & ACQUISITIONS
12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
12.9. EXPANSIONS
12.10. REGULATORY CHANGES
12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES
13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES
13.1 WELCH ALLYN
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL ANALYSIS
13.1.3 PRODUCT MATRIX
13.1.4 RECENT DEVELOPMENTS
13.1.5 DATABRIDGE ANALYSIS
13.2 MIDMARK CORP.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL ANALYSIS
13.2.3 PRODUCT MATRIX
13.2.4 RECENT DEVELOPMENTS
13.2.5 DATABRIDGE ANALYSIS
13.3 FUTUREMED
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL ANALYSIS
13.3.3 PRODUCT MATRIX
13.3.4 RECENT DEVELOPMENTS
13.3.5 DATABRIDGE ANALYSIS
13.4 COSMED
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL ANALYSIS
13.4.4 PRODUCT MATRIX
13.4.4 RECENT DEVELOPMENTS
13.4.5 DATABRIDGE ANALYSIS
13.5 MGC DIAGNOSTICS CORPORATION
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL ANALYSIS
13.5.3 PRODUCT MATRIX
13.5.4 RECENT DEVELOPMENTS
13.5.5 DATABRIDGE ANALYSIS
13.6 NIHON KOHDEN CORPORATION
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL ANALYSIS
13.6.3 PRODUCT MATRIX
13.6.4 RECENT DEVELOPMENTS
13.6.5 DATABRIDGE ANALYSIS
13.7 CAREFUSION CORPORATION
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL ANALYSIS
13.7.3 PRODUCT MATRIX
13.7.4 RECENT DEVELOPMENTS
13.7.5 DATABRIDGE ANALYSIS
13.8 MEDICAL INTERNATIONAL RESEARCH
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL ANALYSIS
13.8.3 PRODUCT MATRIX
13.8.4 RECENT DEVELOPMENTS
13.8.5 DATABRIDGE ANALYSIS
13.9 VITALOGRAPH
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL ANALYSIS
13.9.3 PRODUCT MATRIX
13.9.4 RECENT DEVELOPMENTS
13.9.5 DATABRIDGE ANALYSIS
13.10 NDD MEDICAL TECHNOLOGIES, INC.
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL ANALYSIS
13.10.3 PRODUCT MATRIX
13.10.4 RECENT DEVELOPMENTS
13.10.5 DATABRIDGE ANALYSIS
13.11 SCHILLER AG
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL ANALYSIS
13.11.3 PRODUCT MATRIX
13.11.4 RECENT DEVELOPMENTS
13.11.5 DATABRIDGE ANALYSIS
13.12 JONES MEDICAL INSTRUMENT COMPANY
13.12.1 COMPANY OVERVIEW
13.12.2 FINANCIAL ANALYSIS
13.12.3 PRODUCT MATRIX
13.12.4 RECENT DEVELOPMENTS
13.12.5 DATABRIDGE ANALYSIS
14 APPENDIX
15 ABOUT DATA BRIDGE MARKET RESEARCH
